Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase III Randomized Study of Imatinib; with or without Bevacizumab (NSC-704865); in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors NCT #00324987CIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: CompletedReview Status: Completed
